英文摘要
|
After the financial tsunami in 2008, global economic activity fell sharply, or even decline, Governments around the world are all racking their brains, from loose monetary policy to expand public spending to lift the overall job market, global merger and acquisition activity in 2009 following the year bottoming, 2010 strong mergers and acquisitions continue to expand, growth from 2009 to 2.6 trillion global deals amount to 20143.6 trillion
And according to 2014 world top ten mergers and acquisitions activity, we can obviously see di4-6ming mergers and acquisitions activity, a bio-pharmaceutical industry
Due to differences in industry, pharmaceutical companies spent tens of billions of dollars to develop new drugs while selling the patent period has the right, but pressure to patent a second compression profit space, so the stable development is often the problem with drug company problems. For big pharmaceutical companies that have more mature industries face changing, dispersed extended product line, fill the revenue gap under pressure;
The Purpose of this study is the relationship and explore acquisitions and performance trends. Research focused on the following:
The study would emphasize on following two points:
1、 The relationship between Mergers & acguisition and sales performance
2、 Biotechnology industry growth and mergers and acquisitions
The results of this study can be used as references for the future mergers and acquisitions in the pharmaceutical industry elsewhere.
|